Topical Therapy for Androgenetic Alopecia Clinical Trial
A Clinical trial by Pelage Pharmaceuticals announces positive results for a topical therapy for androgenetic alopecia. It is designed to reactivate dormant hair follicle stem cells
This recent NEJM article clearly points to the need for boosters. Health care workers were largely vaccinated in December and January. The majority of the population vaccinated later will likely need boosters for optimal immunity in the fall and coming winter.